Stability Indicating Method Development and Validation for Determination of Abiraterone in Bulk and Pharmaceutical Dosage Forms by RP-HPLC

Authors

  • Pavani Digigam M.Pharmacy, Department of Pharmaceutical Chemistry, CMR of Pharmacy, Hydera
  • Anusha Jeripothula M.Pharmacy, Department of Pharmaceutical Analysis & Quality Assurance, CMR of Pharmacy, Hyderabad
  • K. Abbulu Principle, CMR of Pharmacy, Hyderabad

Abstract

A simple, Precised, Accurate method was developed for the estimation of Abiraterone by RP-HPLC technique. Chromatographic conditions used are stationary phase Discovery C18 150mm x 4.6 mm, 5m ,Mobile phase 0.01% KH2PO4:Acetonitrile  in the ratio of 60:40 and flow rate was maintained at 1.1 ml/min, detection wave length was 235 nm, column temperature was set to 30oC and diluent was mobile phase Conditions were finalized as optimized method. System suitability parameters were studied by injecting the standard six times and results were well under the acceptance criteria. Linearity study was carried out between 25% to150 % levels, R2 value was found to be as 0.999. Precision was found to be 0.6 for repeatability and 0.2for intermediate precision. LOD and LOQ are 0.953µg/ml and 2.888µg/ml respectively. By using above method assay of marketed formulation was carried out 99.90% was present. Degradation studies of Abiraterone were done, in all conditions purity threshold was more than purity angle and within the acceptable range.

Downloads

Published

2020-07-31

How to Cite

Pavani Digigam, Anusha Jeripothula, & K. Abbulu. (2020). Stability Indicating Method Development and Validation for Determination of Abiraterone in Bulk and Pharmaceutical Dosage Forms by RP-HPLC. World Journal of Pharmaceutical Sciences, 8(8), 119–125. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/1

Issue

Section

Research Article